QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
NASDAQ:SYRS

Syros Pharmaceuticals News Headlines

$2.42
-0.27 (-10.04%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.40
$2.63
50-Day Range
$2.69
$4.33
52-Week Range
$2.40
$15.49
Volume
377,092 shs
Average Volume
361,880 shs
Market Capitalization
$149.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.81
Get Syros Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYRS and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Syros Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SYRS
News Sentiment

0.01

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SYRS Articles
This Week

3

1

SYRS Articles
Average Week



Syros Pharmaceuticals (NASDAQ:SYRS) News Headlines Today

SourceHeadline
MarketBeat logo Brokerages Anticipate Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Will Announce Earnings of -$0.44 Per Share
americanbankingnews.com - January 16 at 4:12 PM
nasdaq.com logoSyros Pharmaceuticals Inc. Shares Approach 52-Week Low - Market Mover
nasdaq.com - January 12 at 9:12 AM
seekingalpha.com logoSyros outlines clinical updates and 2022 goals
seekingalpha.com - January 11 at 8:08 AM
MarketBeat logoPiper Sandler Lowers Syros Pharmaceuticals (NASDAQ:SYRS) Price Target to $10.00
americanbankingnews.com - January 10 at 11:28 PM
finance.yahoo.com logoSyros Announces Clinical Updates and 2022 Goals to Support its Advancement to a Fully Integrated Biopharmaceutical Company
finance.yahoo.com - January 10 at 10:59 AM
finance.yahoo.com logoHere's Why Syros Pharmaceuticals (NASDAQ:SYRS) Can Manage Its Debt Despite Losing Money
finance.yahoo.com - December 28 at 2:58 PM
nasdaq.com logoSyros Pharmaceuticals (NASDAQ:SYRS) Is Using Debt Safely
nasdaq.com - December 13 at 2:21 PM
finance.yahoo.com logoSyros to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 16 at 12:28 PM
finance.yahoo.com logoSyros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
finance.yahoo.com - November 5 at 8:55 AM
benzinga.com logoEarnings Preview For Syros Pharmaceuticals
benzinga.com - November 4 at 12:46 PM
finance.yahoo.com logoSyros Pharmaceuticals (NASDAQ:SYRS) investors are sitting on a loss of 63% if they invested five years ago
finance.yahoo.com - October 29 at 1:48 PM
finance.yahoo.com logoSyros to Report Third Quarter 2021 Financial Results on Friday, November 5, 2021
finance.yahoo.com - October 29 at 7:54 AM
finance.yahoo.com logoSyros Pharmaceuticals, Inc. (SYRS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 28 at 4:53 PM
finance.yahoo.com logoSyros Reports Inducement Grant to Chief Financial Officer under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - October 13 at 8:56 PM
nasdaq.com logoThe past five years for Syros Pharmaceuticals (NASDAQ:SYRS) investors has not been profitable
nasdaq.com - October 12 at 6:11 PM
finance.yahoo.com logoSyros Pharmaceuticals Announces Appointment of Jason Haas as Chief Financial Officer
finance.yahoo.com - October 12 at 1:11 PM
finance.yahoo.com logoCathie Wood is Dumping These 15 Stocks
finance.yahoo.com - September 30 at 2:43 PM
finance.yahoo.com logoSyros Announces First Patient in Dose Confirmation Study of SY-2101, a Novel Oral Form of Arsenic Trioxide, in Acute Promyelocytic Leukemia
finance.yahoo.com - September 29 at 6:22 PM
finance.yahoo.com logoSyros Reports Inducement Grant to Chief Commercial Officer under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - September 29 at 12:34 AM
finance.yahoo.com logoSyros Announces Appointment of Conley Chee as Chief Commercial Officer
finance.yahoo.com - September 27 at 9:42 AM
finance.yahoo.com logoSyros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings
finance.yahoo.com - September 20 at 8:30 PM
finance.yahoo.com logoSyros Presents New Data from Phase 1 Trial of SY-5609 and Details Three-Pronged Combination Strategy to Advance SY-5609 in Solid Tumors and Blood Cancer
finance.yahoo.com - September 20 at 3:28 PM
finance.yahoo.com logoAre Options Traders Betting on a Big Move in Syros (SYRS) Stock?
finance.yahoo.com - September 20 at 10:28 AM
finance.yahoo.com logoSyros to Present New Data from Phase 1 Clinical Trial of SY-5609 in Oral Presentation at ESMO Congress 2021
finance.yahoo.com - September 13 at 7:22 AM
finance.yahoo.com logoSyros Announces Appointment of Deborah Dunsire, M.D., to Its Board of Directors
finance.yahoo.com - September 10 at 6:14 PM
finance.yahoo.com logoSyros to Present at Upcoming Investor Conferences in September
finance.yahoo.com - September 7 at 4:23 PM
bizjournals.com logoIn a highly vaccinated field, life sciences leaders weigh mandates
bizjournals.com - August 19 at 7:54 AM
nasdaq.com logoSyros Pharma Reaches Deal With Roche On Colorectal Cancer Treatment
nasdaq.com - August 5 at 1:39 PM
seekingalpha.com logoSyros Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 5 at 11:37 AM
finance.yahoo.com logoSyros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer
finance.yahoo.com - August 5 at 8:38 AM
finance.yahoo.com logoSyros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
finance.yahoo.com - August 5 at 8:38 AM
markets.businessinsider.com logoSyros Pharmaceuticals Inc hosts conference call for investors
markets.businessinsider.com - July 30 at 7:49 PM
finance.yahoo.com logoSyros to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
finance.yahoo.com - July 29 at 8:33 AM
finance.yahoo.com logoWere Hedge Funds Right About Syros Pharmaceuticals, Inc. (SYRS)?
finance.yahoo.com - July 26 at 3:05 PM
nasdaq.com logoSyros Pharmaceuticals, Inc. Common Stock (SYRS)
nasdaq.com - July 17 at 7:32 PM
finance.yahoo.com logoSyros Pharmaceuticals, Inc. (SYRS)
finance.yahoo.com - July 16 at 6:53 PM
nasdaq.com logoSyros Pharmaceuticals, Inc. Rings The Nasdaq Stock Market Closing Bell
nasdaq.com - June 30 at 6:04 PM
finance.yahoo.com logoSyros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference
finance.yahoo.com - June 9 at 1:03 PM
finance.yahoo.com logoSyros Pharma Skyrockets on Oppenheimer Buy Rating
finance.yahoo.com - May 27 at 6:34 PM
247wallst.com logoCathie Wood's ARK Invest Sells 3.6 Million Shares of Syros Pharma
247wallst.com - May 27 at 1:33 PM
nasdaq.com logoSyros Pharma - Growing Pipeline & Cash Runway
nasdaq.com - May 27 at 1:33 PM
ca.finance.yahoo.com logoSyros Pharmaceuticals Stock Appears To Be Possible Value Trap
ca.finance.yahoo.com - May 20 at 9:24 AM
finance.yahoo.com logoSyros to Host Key Opinion Leader Webcast Series on Targeted Hematology Portfolio
finance.yahoo.com - May 19 at 1:30 PM
seekingalpha.com logoSyros Pharmaceuticals (SYRS) CEO Nancy Simonian on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 7:07 AM
nasdaq.com logoIs Syros Pharmaceuticals (NASDAQ:SYRS) Using Too Much Debt?
nasdaq.com - May 10 at 9:05 PM
finance.yahoo.com logoSyros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
finance.yahoo.com - May 6 at 9:05 AM
benzinga.com logoEarnings Outlook For Syros Pharmaceuticals
benzinga.com - May 5 at 1:03 PM
finance.yahoo.com logoSyros to Report First Quarter 2021 Financial Results on Thursday May 6, 2021
finance.yahoo.com - April 29 at 10:29 AM
finance.yahoo.com logoHow Much Are Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Insiders Spending On Buying Shares?
finance.yahoo.com - March 30 at 3:51 PM
finance.yahoo.com logoSyros Pharmaceuticals, Inc. (SYRS) Stock Jumps 7.2%: Will It Continue to Soar?
finance.yahoo.com - March 22 at 11:59 AM
Get Syros Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYRS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.